DNA ligase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 19: Line 19:
Human LigD IV contains several domains: DNA-binding domain (residues 1-240); adenylation domain (residues 268-405) and the ca. 100 amino acid long BRCT motifs (residues 654-911).  In the ATP-dependent LigD the ATP binds between 2 symmetry related LigD molecules.
Human LigD IV contains several domains: DNA-binding domain (residues 1-240); adenylation domain (residues 268-405) and the ca. 100 amino acid long BRCT motifs (residues 654-911).  In the ATP-dependent LigD the ATP binds between 2 symmetry related LigD molecules.
*<scene name='44/443730/Cv/4'>ATP binding site</scene> in ATP-dependent DNA ligase from ''S. solfataricus'' ([[2hix]]). <ref>PMID:17052461</ref>  
*<scene name='44/443730/Cv/4'>ATP binding site</scene> in ATP-dependent DNA ligase from ''S. solfataricus'' ([[2hix]]). <ref>PMID:17052461</ref>  
== 3D Structures of DNA ligase ==
[[DNA ligase 3D structures]]
</StructureSection>
</StructureSection>


Line 38: Line 42:
**[[4eq5]] – LigD + AMP – ''Thermococcus sibiricus''<br />
**[[4eq5]] – LigD + AMP – ''Thermococcus sibiricus''<br />
**[[4d05]] – LigD + AMP - ''Psychromonas'' <br />
**[[4d05]] – LigD + AMP - ''Psychromonas'' <br />
**[[6nhx]], [[6nhz]] – MtLigD D + ATP - ''Mycobacterium tuberculosis'' <br />


*NAD+-dependent LigD
*NAD+-dependent LigD
Line 45: Line 50:
**[[3ba8]], [[3ba9]], [[3baa]], [[3bab]], [[3bac]], [[4eeq]], [[4efb]], [[4efe]], [[4lh6]], [[4lh7]] - EfLigD adenylation domain + NMN + inhibitor – ''Enterococcus faecalis''<br />
**[[3ba8]], [[3ba9]], [[3baa]], [[3bab]], [[3bac]], [[4eeq]], [[4efb]], [[4efe]], [[4lh6]], [[4lh7]] - EfLigD adenylation domain + NMN + inhibitor – ''Enterococcus faecalis''<br />
**[[1ta8]], [[1tae]] - EfLigD adenylation domain<br />
**[[1ta8]], [[1tae]] - EfLigD adenylation domain<br />
**[[1zau]] - MtLigD adenylation domain – ''Mycobacterium tuberculosis''<br />
**[[1zau]] - MtLigD adenylation domain <br />
**[[3sgi]] – MtLigD (mutant) + AMP<br />
**[[3sgi]] – MtLigD (mutant) + AMP<br />
**[[1v9p]], [[1dgs]] – LigD – ''Thermos filiformis''<br />
**[[1v9p]], [[1dgs]] – LigD – ''Thermos filiformis''<br />
Line 58: Line 63:


**[[2q2t]] – CvLigD + DNA + AMP + CMP – Chlorella virus<br />
**[[2q2t]] – CvLigD + DNA + AMP + CMP – Chlorella virus<br />
**[[6imj]], [[6imk]], [[6iml]], [[6imn]] – LigD + DNA – African swine fever virus<br />
**[[6gdr]] – LigD + DNA – ''Alteromonas mediterranea''<br />
**[[6dt1]] – T4LigD + DNA – phage T4<br />
**[[5wfy]] – T4LigD DNA-binding domain <br />
**[[2q2u]], [[ 1p8l]], [[ 1fvi]] - CvLigD + DNA + mononucleotide<br />
**[[2q2u]], [[ 1p8l]], [[ 1fvi]] - CvLigD + DNA + mononucleotide<br />
**[[2owo]] – LigD + DNA + AMP + CMP – ''Escherichia coli''<br />
**[[2owo]] – LigD + DNA + AMP + CMP – ''Escherichia coli''<br />
Line 84: Line 93:
**[[3w5o]] - hLigD IV <br />
**[[3w5o]] - hLigD IV <br />
**[[2e2w]] - hLigD IV BRCT domain - NMR<br />
**[[2e2w]] - hLigD IV BRCT domain - NMR<br />
**[[1z56]] – LigD IV + ligase interacting factor 1 - yeast<br />
**[[3vnn]] - hLigD IV adenylation domain<br />
**[[3vnn]] - hLigD IV adenylation domain<br />
**[[4hto]] - hLigD IV DNA-binding domain<br />
**[[4hto]] - hLigD IV DNA-binding domain<br />
**[[4htp]] - hLigD IV DNA-binding domain + artemis protein peptide<br />
**[[4htp]] - hLigD IV DNA-binding domain + artemis protein peptide<br />
**[[3w1b]], [[3w1g]] - hLigD IV adenylation and DNA-binding domains + artemis protein peptide<br />
**[[3w1b]], [[3w1g]] - hLigD IV adenylation and DNA-binding domains + artemis protein peptide<br />
**[[6bkg]], [[6bkf]] - hLigD IV + DNA<br />
**[[1z56]] – LigD IV + ligase interacting factor 1 - yeast<br />
}}
}}



Revision as of 07:40, 12 June 2019

ATP-dependent DNA ligase complexed with ATP 2hix

Drag the structure with the mouse to rotate

3D Structures of DNA ligase

Updated on 12-June-2019

References

Elevated expression of DNA ligase I in human cancers., Sun DY, Urrabaz R, Nguyen M, Marty J, Stringer S, Cruz E, Medina-Gundrum L, Weitman S., Clinical Cancer Research. 2001; 7(12):4143-4148.
Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene., Harrison C, Ketchen AM, Redhead NJ, O'Sullivan MJ, Melton DW., Cancer Research. 2002; 62(14):4065-4074.

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel